Biography
Dr. Zil-a-Rubab is a distinguished clinician-researcher based in Melbourne, Australia, with extensive experience in both medical practice and academic research. She holds an MBBS, and a PhD in Biochemistry and Molecular Biology. She is a holder of Cancer Biology & Therapeutics High Impact Cancer Research Course from Harvard Medical School.
Zil’s expertise spans a wide range of areas, including cancer biology, cardiovascular diseases, diabetes mellitus, Pedagogy and AI. She has been involved in numerous high-impact research projects and has developed innovative techniques. Her work has led to significant contributions in the fields of clinical trials, research governance, and the development of policy guidelines. Currently, Dr. Zil is involved in teaching Cell/Mol Biology and Biomedical Sciences at Federation University.
Throughout her career, Zil has held various prestigious positions, Medical Monitor at George Clinical- Sydney and HREC member at Nutromics Diagnostics. She has also served as Chairperson of the Clinical Research Division at Ziauddin University-Hospital, where she managed and evaluated clinical research projects and established collaborative networks with healthcare partners. She is also an accomplished educator, having developed and delivered numerous educational programs and workshops. Her dedication to research and education has earned her a respected place in the global scientific community.
Available for
HDR Supervision
Professional Comment
HDR Examiner
- Publications
Genetic variations and lifestyle in oxidative stress
- Book Chapters
- DOI reference: 10.1016/B978-0-443-18807-7.00006-5
Identification of a Single Nucleotide Polymorphism of Vitamin D Receptor (VDR) and Vitamin D Binding Protein (VDBP) Gene and Its Dysregulated Pathway Through VDR-VDBP Interaction Network Analysis in Vitamin D-Deficient Infertile Females
- Journals
- DOI reference: 10.7759/cureus.55602
IS tRNA driving breast cancer progression?
- Journals
- DOI reference: 10.36283/PJMD8-4/011
Co-Stimulatory Markers OX40 and OX40L in Blood and Saliva of Oral Squamous Cell Carcinoma: A Comparative Study
- Journals
- DOI reference: 10.17582/journal.pjz/2022020505024